US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist
  • 0.4850
  • -0.0050-1.02%
Close Nov 26 16:00 ET
  • 0.4919
  • +0.0069+1.42%
Pre 08:55 ET
10.21MMarket Cap-16166P/E (TTM)

T2 Biosystems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
34.85%1.99M
-0.61%1.95M
-0.82%2.06M
-67.75%7.19M
-69.38%1.68M
-59.97%1.47M
-66.77%1.96M
-71.27%2.08M
-20.50%22.31M
-21.45%5.48M
Operating revenue
34.85%1.99M
-0.61%1.95M
-0.82%2.06M
-67.75%7.19M
-69.38%1.68M
-59.97%1.47M
-66.77%1.96M
-71.27%2.08M
-20.50%22.31M
-21.45%5.48M
Cost of revenue
4.48%4.1M
-44.69%2.69M
5.18%4.2M
-26.88%15.36M
-29.27%2.57M
-35.50%3.93M
-4.17%4.87M
-35.62%4M
1.48%21.01M
-32.13%3.64M
Gross profit
13.74%-2.12M
74.49%-741K
-11.68%-2.14M
-730.89%-8.17M
-148.54%-895K
-1.87%-2.45M
-450.00%-2.91M
-286.30%-1.92M
-82.39%1.3M
13.97%1.84M
Operating expense
-6.92%8.05M
-12.93%8.83M
-11.14%10.46M
-30.81%38.98M
-24.87%8.42M
-35.46%8.64M
-35.98%10.15M
-25.91%11.77M
11.95%56.34M
-5.75%11.21M
Selling and administrative expenses
-10.07%5.38M
-13.07%5.47M
-7.69%6.74M
-18.92%24.83M
-19.82%5.26M
-14.78%5.98M
-19.53%6.3M
-20.92%7.3M
7.35%30.63M
0.15%6.55M
Research and development costs
0.15%2.67M
-12.70%3.36M
-16.77%3.72M
-44.96%14.15M
-31.98%3.17M
-58.23%2.66M
-52.02%3.85M
-32.83%4.47M
17.95%25.72M
-12.96%4.66M
Operating profit
8.43%-10.16M
26.63%-9.58M
7.94%-12.6M
14.34%-47.15M
0.53%-9.32M
29.77%-11.1M
13.10%-13.05M
7.88%-13.69M
-28.09%-55.05M
8.85%-9.37M
Net non-operating interest income expense
66.93%-370K
68.98%-478K
22.54%-1.18M
12.18%-5.34M
24.02%-1.16M
28.27%-1.12M
-14.66%-1.54M
7.59%-1.52M
18.71%-6.08M
17.85%-1.53M
Non-operating interest expense
-66.93%370K
-68.98%478K
-22.54%1.18M
-12.18%5.34M
-24.02%1.16M
-28.27%1.12M
14.49%1.54M
-7.76%1.52M
-19.91%6.08M
-21.80%1.53M
Other net income (expense)
112.90%414K
-86.78%1.09M
108.89%245K
376.77%2.42M
-82.46%140K
-21,300.00%-3.21M
593.42%8.25M
-30,722.22%-2.76M
-171.88%-874K
16,060.00%798K
Gain on sale of security
153.35%398K
-87.12%1.06M
96.14%-80K
811.94%5.43M
-96.36%31K
-1,303.23%-746K
590.39%8.21M
-18,954.55%-2.07M
-175.45%-762K
503.32%851K
Special income (charges)
--0
----
----
-1,562.91%-2.51M
--0
---2.51M
----
----
---151K
---151K
-Less:Impairment of capital assets
--0
----
----
1,562.91%2.51M
--0
--2.51M
----
----
--151K
--151K
Other non- operating income (expenses)
-65.96%16K
3.23%32K
147.65%325K
-1,369.23%-495K
11.22%109K
161.04%47K
675.00%31K
-34,000.00%-682K
-81.07%39K
--98K
Income before tax
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
Income tax
Net income
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
Net income continuous Operations
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
Minority interest income
Net income attributable to the parent company
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
Preferred stock dividends
330K
0
Other preferred stock dividends
Net income attributable to common stockholders
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.66%-50.08M
-2.39%-10.34M
12.88%-15.43M
64.81%-6.35M
-8.91%-17.97M
-26.59%-62.33M
16.84%-10.1M
Basic earnings per share
83.48%-0.57
91.84%-0.64
97.98%-2.66
98.43%-19.19
98.19%-2.5478
98.83%-3.45
98.46%-7.84
72.89%-131.77
21.15%-1.22K
-1,914.29%-141
Diluted earnings per share
83.48%-0.57
91.84%-0.64
97.98%-2.66
98.43%-19.19
98.19%-2.5478
98.83%-3.45
98.46%-7.84
72.89%-131.77
21.15%-1.22K
-1,914.29%-141
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 34.85%1.99M-0.61%1.95M-0.82%2.06M-67.75%7.19M-69.38%1.68M-59.97%1.47M-66.77%1.96M-71.27%2.08M-20.50%22.31M-21.45%5.48M
Operating revenue 34.85%1.99M-0.61%1.95M-0.82%2.06M-67.75%7.19M-69.38%1.68M-59.97%1.47M-66.77%1.96M-71.27%2.08M-20.50%22.31M-21.45%5.48M
Cost of revenue 4.48%4.1M-44.69%2.69M5.18%4.2M-26.88%15.36M-29.27%2.57M-35.50%3.93M-4.17%4.87M-35.62%4M1.48%21.01M-32.13%3.64M
Gross profit 13.74%-2.12M74.49%-741K-11.68%-2.14M-730.89%-8.17M-148.54%-895K-1.87%-2.45M-450.00%-2.91M-286.30%-1.92M-82.39%1.3M13.97%1.84M
Operating expense -6.92%8.05M-12.93%8.83M-11.14%10.46M-30.81%38.98M-24.87%8.42M-35.46%8.64M-35.98%10.15M-25.91%11.77M11.95%56.34M-5.75%11.21M
Selling and administrative expenses -10.07%5.38M-13.07%5.47M-7.69%6.74M-18.92%24.83M-19.82%5.26M-14.78%5.98M-19.53%6.3M-20.92%7.3M7.35%30.63M0.15%6.55M
Research and development costs 0.15%2.67M-12.70%3.36M-16.77%3.72M-44.96%14.15M-31.98%3.17M-58.23%2.66M-52.02%3.85M-32.83%4.47M17.95%25.72M-12.96%4.66M
Operating profit 8.43%-10.16M26.63%-9.58M7.94%-12.6M14.34%-47.15M0.53%-9.32M29.77%-11.1M13.10%-13.05M7.88%-13.69M-28.09%-55.05M8.85%-9.37M
Net non-operating interest income expense 66.93%-370K68.98%-478K22.54%-1.18M12.18%-5.34M24.02%-1.16M28.27%-1.12M-14.66%-1.54M7.59%-1.52M18.71%-6.08M17.85%-1.53M
Non-operating interest expense -66.93%370K-68.98%478K-22.54%1.18M-12.18%5.34M-24.02%1.16M-28.27%1.12M14.49%1.54M-7.76%1.52M-19.91%6.08M-21.80%1.53M
Other net income (expense) 112.90%414K-86.78%1.09M108.89%245K376.77%2.42M-82.46%140K-21,300.00%-3.21M593.42%8.25M-30,722.22%-2.76M-171.88%-874K16,060.00%798K
Gain on sale of security 153.35%398K-87.12%1.06M96.14%-80K811.94%5.43M-96.36%31K-1,303.23%-746K590.39%8.21M-18,954.55%-2.07M-175.45%-762K503.32%851K
Special income (charges) --0---------1,562.91%-2.51M--0---2.51M-----------151K---151K
-Less:Impairment of capital assets --0--------1,562.91%2.51M--0--2.51M----------151K--151K
Other non- operating income (expenses) -65.96%16K3.23%32K147.65%325K-1,369.23%-495K11.22%109K161.04%47K675.00%31K-34,000.00%-682K-81.07%39K--98K
Income before tax 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M
Income tax
Net income 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M
Net income continuous Operations 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M
Minority interest income
Net income attributable to the parent company 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M
Preferred stock dividends 330K0
Other preferred stock dividends
Net income attributable to common stockholders 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.66%-50.08M-2.39%-10.34M12.88%-15.43M64.81%-6.35M-8.91%-17.97M-26.59%-62.33M16.84%-10.1M
Basic earnings per share 83.48%-0.5791.84%-0.6497.98%-2.6698.43%-19.1998.19%-2.547898.83%-3.4598.46%-7.8472.89%-131.7721.15%-1.22K-1,914.29%-141
Diluted earnings per share 83.48%-0.5791.84%-0.6497.98%-2.6698.43%-19.1998.19%-2.547898.83%-3.4598.46%-7.8472.89%-131.7721.15%-1.22K-1,914.29%-141
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday-0.11%